Actual Medicinal Product (AMP) Efexor XL 225mg capsules (Viatris UK Healthcare Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
- There are no stability notes available for this medicine.
- Provenance
-
This recommendation is based on the products Efexor XL 225mg prolonged release capsules (Upjohn UK Limited) and venlafaxine 225mg prolonged release hard capsules (Genus Pharmaceuticals).
- Generic
- Venlafaxine
- Formulation
- Venlafaxine 225mg modified-release capsules
-
Venlafaxine
-
Venlafaxine 225mg modified-release capsules
-
Efexor XL 225mg capsules (Viatris UK Healthcare Ltd)
-
-